BRIEF published on 12/03/2024 at 14:34, 1 year ago Eckert & Ziegler Announces Executive and Supervisory Board Changes Executive Board Supervisory Board Eckert & Ziegler Dr. Gunnar Mann Jutta Ludwig
BRIEF published on 12/03/2024 at 14:34, 1 year ago Eckert & Ziegler annonce des changements au sein de son conseil d'administration et de son conseil de surveillance Eckert & Ziegler Conseil De Surveillance Conseil Exécutif Jutta Ludwig Dr Gunnar Mann
PRESS RELEASE published on 12/03/2024 at 14:29, 1 year ago Eckert & Ziegler: Changes in the Executive Board and Supervisory Board Eckert & Ziegler SE appoints Dr. Gunnar Mann to Executive Board and welcomes changes in Supervisory Board. Dr. Mann to lead Medical segment Executive Board Supervisory Board Eckert & Ziegler SE Medical Segment Dr. Gunnar Mann
BRIEF published on 12/02/2024 at 09:05, 1 year ago Eckert & Ziegler Initiates Actinium-225 Production to Tackle Global Shortage Nuclear Medicine Radiopharmaceuticals Actinium-225 Production Isotope Supply GMP Certification
BRIEF published on 12/02/2024 at 09:05, 1 year ago Eckert & Ziegler lance la production d'actinium 225 pour faire face à la pénurie mondiale Produits Radiopharmaceutiques Médecine Nucléaire Production D'actinium 225 Approvisionnement En Isotopes Certification GMP
PRESS RELEASE published on 12/02/2024 at 09:00, 1 year ago Eckert & Ziegler Begins Production of Actinium-225, Paving the Way for GMP-Grade Supply Eckert & Ziegler starts Actinium-225 production in collaboration with Czech Academy of Sciences, aiming for GMP-grade supply to boost alpha-emitting radiopharmaceuticals development Eckert & Ziegler Production Radiopharmaceuticals Actinium-225 GMP-grade
BRIEF published on 11/27/2024 at 09:05, 1 year ago Eckert & Ziegler Gains European Approval for Theralugand® Cancer Therapy Radiopharmaceuticals Lutetium-177 European Approval Theralugand®
BRIEF published on 11/27/2024 at 09:05, 1 year ago Eckert & Ziegler obtient l'approbation européenne pour Theralugand® Produits Radiopharmaceutiques Thérapie Contre Le Cancer Lutetium-177 Theralugand® Agrément Européen
PRESS RELEASE published on 11/27/2024 at 09:00, 1 year ago Eckert & Ziegler Achieves European Approval for Theralugand® - Lutetium-177 Chloride (n.c.a) Eckert & Ziegler receives EC approval for Theralugand® - Lutetium-177 Chloride, expanding cancer therapy options in Europe Eckert & Ziegler Cancer Therapy EC Approval Theralugand Lutetium-177 Chloride
BRIEF published on 11/22/2024 at 15:32, 1 year ago Eckert & Ziegler Increases 2024 Financial Forecast Eckert & Ziegler Sales Increase Financial Forecast EBIT Growth 2024 Business
Published on 12/05/2025 at 19:50, 6 minutes ago Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 36 minutes ago The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 1 hour 11 minutes ago Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 36 minutes ago NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 56 minutes ago SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 18:58, 57 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 1 hour 40 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 2 hours 9 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 2 hours 38 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 38 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 45 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 45 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 57 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
